Rwanda vs Western Pacific (WHO region): Confirmed cases of MDR-TB started treatment for MDR-TB
Rwanda
100.0%
in 2012
Western Pacific (WHO region)
73.0%
in 2012
Rwanda rank
3rd
Western Pacific (WHO region) rank
6th
Confirmed cases of MDR-TB started treatment for MDR-TB over time
- Rwanda
- Western Pacific (WHO region)
How they compare
Rwanda currently reports 100.0% against 73.0% in Western Pacific (WHO region), a difference of 27.0%.
That makes Rwanda's figure about 1.4 times Western Pacific (WHO region)'s.
Across all 5 years both countries report, Rwanda has been ahead every year.
Rwanda ranks 3rd and Western Pacific (WHO region) ranks 6th of 54 countries.
Rwanda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Rwanda | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 90.0% | 58.5% | 31.5% | Rwanda |
| 2010s | 97.7% | 61.7% | 36.0% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of mdr-tb started treatment for mdr-tb, Rwanda or Western Pacific (WHO region)?
- Rwanda, at 100.0% against 73.0% in Western Pacific (WHO region) as of 2012.
- What is the difference in confirmed cases of mdr-tb started treatment for mdr-tb between Rwanda and Western Pacific (WHO region)?
- 27.0%, with Rwanda ahead.
- How many years of comparable data are there for Rwanda and Western Pacific (WHO region)?
- 5 years are reported by both, from 2008 to 2012.
- How do Rwanda and Western Pacific (WHO region) rank globally for confirmed cases of mdr-tb started treatment for mdr-tb?
- Rwanda ranks 3rd and Western Pacific (WHO region) ranks 6th of 54 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of MDR-TB started treatment for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.